The efficacy and safety of modified DEB-TACE in the treatment of unresectable large hypervascular hepatocellular carcinoma
Objective To retrospectively analyze the clinical efficacy and safety of the modified drug-eluting beads transcatheter arterial chemoembolization (DEB-TACE) in the treatment of unresectable large hypervascular hepatocellular carcinoma. Methods A retrospective analysis was conducted on the clinical...
Saved in:
Main Author: | LIU Song, LI Long, WANG Qingdong, YU Guangji |
---|---|
Format: | Article |
Language: | zho |
Published: |
The Editorial Department of Chinese Journal of Clinical Research
2024-11-01
|
Series: | Zhongguo linchuang yanjiu |
Subjects: | |
Online Access: | http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20241120 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma
by: Wu Y, et al.
Published: (2025-02-01) -
Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma
by: Haohao Lu, et al.
Published: (2024-11-01) -
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION IN THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA ON ADVANCED LIVER CIRRHOSIS
by: A. S. Polekhin, et al.
Published: (2020-03-01) -
Efficacy analysis of drug-eluting beads transcatheter arterial chemoembolization combining systemic chemotherapy and immune checkpoint inhibitors in unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study based on propensity score matching
by: Liu Song, et al.
Published: (2025-01-01) -
Survival benefit from adjuvant TACE combined with lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy
by: Lei Liang, et al.
Published: (2024-12-01)